Emmes Acquires Institut Dr. Schauerte


Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, has announced that it has acquired Institut Dr. Schauerte, a CRO headquartered in Munich, Germany. Founded in 1990, Institut Dr. Schauerte is a full-service, technology-oriented CRO that specializes in late-phase, non-interventional, and post-market clinical follow-up studies. It has conducted more than 400 studies across a range of therapeutic areas.

Dr. Schauerte and Institut Dr. Schauerte's leaders and staff will continue in their current roles.

Emmes Acquires Institut Dr. Schauerte, Entering Real World Evidence Market

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.